| 1 |
32566257 | Metformin effectively treats Tsc1 deletion-caused kidney pathology by upregulating AMPK phosphorylation. | 2020 |
1 |
| 2 |
25688512 | Rationale and protocol of the MetNET-1 trial, a prospective, single center, phase II study to evaluate the activity and safety of everolimus in combination with octreotide LAR and metformin in patients with advanced pancreatic neuroendocrine tumors. | 2014 Nov-Dec |
1 |
| 3 |
22363765 | Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC). | 2012 |
2 |
| 4 |
20444419 | Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. | 2010 May 5 |
1 |
| 5 |
20668229 | The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation. | 2010 Nov 18 |
1 |